StockData
Biodesix Inc logo

Biodesix Inc (BDSX) stock

BDSXNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 4/30
$9.00−0.88 (-8.91%)

Close on Nov 16, 2026Market cap $94.96MP/E –Yield –

Biodesix price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Biodesix's price to book ratio was 11.7× on Nov 11, 2026, against 5.5× a year earlier. Over the last 4 years it ranged from 3.7× to 479.9×, with a median of 136.1×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202611.7×−81.5
2025Jul 31, 202593.1×−66.7
2024Dec 31, 2024159.8×−248.1
2023Jul 31, 2023407.9×+302.6
2022Oct 31, 2022105.3×−73.0
2021Dec 31, 2021178.3×–

More Biodesix figures

See a number that looks wrong?